InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,910.80
(
-0.88%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.22
(
-0.01%
)
Bitcoin
63,453.76
(
-1.29%
)
Post# of 3329
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 117
Posts 20162
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: fsulevine post# 3025

Thursday, 07/27/2017 11:38:01 AM

Thursday, July 27, 2017 11:38:01 AM

Post# of 3329
FS Thx for clarifying that .
I briefly asked if they were prescribing Auryxia in her dept . To her knowledge only 1 patient was on it as insurance providers demanded patient fail existing treatments first and required extensive paper work to enable a switch .

Will try and get more detail this evening .
The 2 CKD drugs in development that her Dept seemed most interested in, are being developed by FGEN and OMER

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up